drugset / Trial / NCT01161888

Effect of Topical Imiquimod on Lentigo Maligna

NCT01161888

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if topical imiquimod is effective in the pathological complete regression of lentigo maligna.

Timeline

Start
2010-06
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 250 mg Topical